Search This Blog

Thursday, September 22, 2022

Illumina's Grail expands use of cancer detection test with life insurer deal

 Cancer detection test maker Grail, acquired by Illumina Inc (ILMN.O) last year despite ongoing antitrust challenges, on Tuesday said it would expand use of its flagship Galleri test through a new agreement with life insurer John Hancock, a division of Manulife Financial (MFC.TO).

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.